A reliance on vaccines in short supply and questions over their best use are hampering efforts to curb the global spread of monkeypox which has hit dozens of countries for the first time, health officials say.
https://www.pharmalive.com/wp-content/uploads/2022/06/Reutersmonkeypox6-3-2022.jpg8001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-08-23 03:27:002022-08-23 11:44:54Analysis: Experts question reliance on monkeypox vaccine with little data, short supply